Walmart, CVS to halt filling prescriptions for controlled substances
New Delhi: Walmart Inc and CVS Health Corp said on Wednesday they will stop filling prescriptions for controlled substances issued by telehealth startups Cerebral Inc and Done Health.Cerebral and Done are known for treating patients with ADHD, prescribing stimulants such as Adderall.Walmart confirmed the move to Reuters and said the decision was made after an audit and compliance process.CVS...
Login or Register to read the full article
New Delhi: Walmart Inc and CVS Health Corp said on Wednesday they will stop filling prescriptions for controlled substances issued by telehealth startups Cerebral Inc and Done Health.
Cerebral and Done are known for treating patients with ADHD, prescribing stimulants such as Adderall.
Walmart confirmed the move to Reuters and said the decision was made after an audit and compliance process.
CVS said it will not accept prescriptions for controlled substances issued by the startups effective May 26, as a result of a review it conducted on the telehealth firms and after it was "unable to resolve concerns we have with Cerebral and Done Health."
Cerebral and Done did not respond to Reuters requests for comment.
According to a Wall Street Journal report earlier this month, Cerebral had been issued a subpoena by federal prosecutors as part of an investigation into possible violations of the Controlled Substances Act.
Read also: Traders body accuses online pharmacies of predatory pricing
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd